The correlation between phubbing and depression anxiety stress of first-year medical students: the mediating role of sedentary behavior
Autonomic nervous system reactions to secondary exposure to disaster-related imagery
Joint latent profiles of death anxiety and treatment adherence in HCC patients
Circling back to RNA vaccines
Nature Biotechnology, Published online: 11 May 2026; doi:10.1038/s41587-026-03155-8
While circRNA is often framed as a more stable, longer-lasting alternative to linear mRNA, its real-world advantages remain largely theoretical, and it is unclear whether greater molecular stability will translate into meaningful clinical gains.
A new treatment for preterm pre-eclampsia could benefit mother and child
Nature Medicine, Published online: 11 May 2026; doi:10.1038/s41591-026-04400-y
A first-in-human trial involving selective removal of the placental protein sFlt-1 in preterm pre-eclampsia provides critical safety data, and could mark the beginning of a new era of targeted therapy for this potentially lethal pregnancy complication.
The connection between periods and mental health
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.
Good morning and happy Monday. Lots of infectious disease reading today, and some political movement, too. I hope your coffee is ready.
Opinion: AI doctors should be licensed. Here’s a framework to do that
Late last month, Utah’s Medical Licensing Board called for the immediate suspension of the state’s pilot program with the AI company Doctronic. The program lets a chatbot evaluate patients and recommend prescription renewals for nearly 200 chronic condition drugs, with the state planning to phase out physician review of each case.
The board said that it only learned about the pilot after it had launched. Its warning was blunt: proceeding without proper clinical oversight “potentially places Utah citizens at risk.”
STAT+: Medicare is spending far less than expected on new Alzheimer’s drugs
People on Medicare are not getting the recently approved Alzheimer’s medications nearly as much as federal officials anticipated.
Uptake for the drugs, Leqembi and Kisunla, has been so muted that Medicare is not forecasting significant spending on them in 2026 or 2027, a spokesperson for the Centers for Medicare and Medicaid Services told STAT. It’s a dramatic shift from two years ago, when Medicare projected it would spend billions of dollars annually on Leqembi alone.
The lower-than-expected spending lines up with the challenges that the Alzheimer’s drugs have faced since their approvals, neurologists and Medicare experts told STAT: The intravenous medications are not easy to administer and require a lot of imaging; the population of eligible patients is limited; and the drugs continue to have little meaningful benefits while carrying a risk of severe side effects like brain bleeding.
Animal skin disease confirmed in clusters of European men who have sex with men
Researchers in France and Spain have diagnosed a number of men who have sex with other men with dermatophilosis, a skin disease that normally infects livestock, even though the cases had no known exposure to affected animals. Cases have also been detected in Germany, one of the researchers told STAT.
The clusters of infections are in some ways reminiscent of the emergence of mpox in 2022 in networks of gay men and other men who have sex with men. But people who have diagnosed some of these dermatophilosis cases describe a disease that is much milder in presentation.

